Before You Sign Wildflower’s New Cigna Contract, Read What Actually Changed

Wildflower Health has issued a new Cigna Lactation Statement of Work effective October 1, 2026.

Providers are understandably noticing the reimbursement increase. The prior agreement paid $175 for an in-person lactation consultation. The new agreement increases that to $182 in most states and $193 in California, Hawaii, Massachusetts, New Jersey, New York, Oregon, Washington, and Washington, D.C. Virtual visits remain $100 and visits involving multiples remain $230.

But the rate increase is not what providers should be paying the most attention to.

The new agreement changes the amount of control Wildflower can exercise over independent lactation practices while leaving some very important questions unanswered:

What authority has the provider actually given Wildflower?

What rules actually come from Cigna?

Why can't providers see the Cigna agreement Wildflower repeatedly relies upon?

Why can Wildflower change its Provider Manual after the contract is signed without obtaining the provider's agreement to those changes?

What happens to money generated by services the independent provider actually performed?

And perhaps most importantly:

Where is Wildflower given authority to submit claims as though Wildflower provided clinical care that was actually rendered by an independent practice?

Those are not minor administrative questions.

They go directly to who controls an independent provider's practice, who owns the receivable generated by that practice's services, and how those clinical services are represented to the payer.

First, understand what this contract actually is

The new document is not a completely new standalone master agreement.

Wildflower and the provider already have a Management Services Agreement, or MSA. The Cigna Lactation Statement of Work operates underneath that agreement.

The original MSA says Wildflower provides management services described in individual Statements of Work, while the contractor provides the services described in those SOWs.

The new October 2026 document expressly says that it supersedes and replaces the previous Cigna Lactation SOW in its entirety.

So providers should not look at this as simply accepting a small fee-schedule update.

They are signing a replacement agreement containing new contractual obligations.

One of those additions is particularly concerning.

The old contract did not bind providers to Wildflower's Provider Manual

The prior Cigna SOW required the contractor to oversee quality, credentialing, service monitoring, patient safety, and risk management.

It then moved directly to the disclaimer section.

There was no provision requiring the contractor to follow a Wildflower Provider Manual.

The new SOW adds one.

The new agreement says the provider acknowledges receipt of Wildflower's Provider Manual. It then says Wildflower may update that Manual “from time to time.”

It goes even further.

The contract says providers may receive additional Wildflower policies in other forms, including FAQs, protocols, guidelines, and other requirements or procedures.

And the contractor agrees to comply with those materials as part of its obligations under the SOW.

That is a significant transfer of control.

You are agreeing today to rules Wildflower can change tomorrow

Read what is missing from that provision.

It does not say Wildflower must obtain the provider's signature before changing the Provider Manual.

It does not require a formal contract amendment.

It does not require mutual agreement.

It does not say the provider must affirmatively accept the new rule.

It does not even limit future requirements to the four corners of the Provider Manual. Wildflower can also issue policies through FAQs, protocols, guidelines, and other communications.

In practical terms, the provider signs the agreement once.

Wildflower can then change the Manual later.

The provider has already agreed that it will comply.

That deserves far more attention than a $7 or $18 reimbursement increase.

Independent providers should know what rules they are agreeing to before they agree to them.

Then there is an even bigger transparency problem: the Cigna agreement providers cannot see

Wildflower's SOW repeatedly relies on another contract:

the Cigna Provider Network Agreement.

The SOW expressly says that the services are being provided in connection with Cigna and the “Cigna Provider Network Agreement.”

The billing section goes even further.

Wildflower is given oversight over methods of collecting accounts receivable, settling disputes regarding charges, and writing off charges.

But those activities are supposed to remain subject to applicable governmental regulations and the terms and conditions of applicable payer agreements.

That same structure remains in the new agreement.

There is one obvious problem:

The independent provider does not have the Cigna Provider Network Agreement.

The SOW does not attach it.

The documents we reviewed do not provide an express contractual right for the contractor to inspect its relevant provisions.

Yet that undisclosed agreement is being invoked as part of the authority governing how the provider's claims are handled.

That creates an enormous verification problem.

What happens when Wildflower says, “Cigna requires this”?

Suppose Wildflower introduces a new billing requirement next year.

A provider objects.

Wildflower responds:

“Cigna requires us to do it this way.”

How does the provider verify that statement?

They cannot simply open the Cigna agreement and read the provision.

They do not have it.

That leaves providers unable to independently determine whether a rule:

• actually came from Cigna;

• represents Wildflower's interpretation of its Cigna agreement;

• is an operational decision made by Wildflower;

• came from the Wildflower Provider Manual; or

• was introduced through a Wildflower FAQ, protocol, or guideline.

That distinction matters.

It is not enough for an intermediary to say that an undisclosed contract gives it authority.

Providers whose NPIs, clinical services, records, and reimbursement are affected should be able to determine what authority actually exists.

And now Wildflower controls another source of rules

The 2026 agreement compounds the problem.

Wildflower can potentially point to two separate sources of authority that the provider did not negotiate directly.

First:

“Cigna requires it.”

But the provider cannot review Wildflower's Cigna agreement.

Second:

“It's in our Provider Manual.”

And Wildflower has reserved the ability to change that Manual after the provider signs.

That is an extraordinary amount of control to hand to an intermediary.

There is also a completely separate claims issue that still has not been answered

There is another problem that has existed throughout this relationship and should not be confused with the Provider Manual issue.

Where is Wildflower actually authorized to submit claims as though Wildflower provided the clinical service?

Because that is not what the provider contract says.

The agreement is very clear about who performs lactation care.

It says the Contractor provides the Lactation Consultation Services.

Those services include in-person home visits, office visits, and virtual telehealth consultations performed by the contractor's IBCLC.

What does Wildflower do?

Wildflower is the Manager.

And when the contract discusses billing, it says:

“Contractor hereby appoints Manager as its billing and collection agent for all fees related to the performance of medical services by Contractor.”

Read that carefully.

Wildflower is appointed the provider's billing and collection agent.

The medical services are performed by the Contractor.

Those are two very different roles.

A billing agent collecting money does not make the clinical receivable its own

There is nothing unusual about a healthcare practice hiring someone else to handle its claims.

Medical billing companies do it every day.

A biller can prepare a claim.

A biller can transmit a claim.

A biller can follow up with the payer.

And, when appropriately authorized, a billing or collection agent can receive funds on behalf of the provider.

That last phrase matters.

The fact that an agent touches the payment does not, by itself, establish that the agent furnished the healthcare service or that the underlying receivable became the agent's clinical revenue.

The agreement here says Wildflower is collecting fees related to medical services performed by the Contractor.

It does not say that the contractor sells or assigns the underlying clinical services to Wildflower.

It does not say Wildflower becomes the owner of the contractor's clinical receivable.

It does not say the contractor becomes a Wildflower group-practice member.

It does not say Wildflower becomes the clinician that treated the patient.

The commercial arrangement here needs to be evaluated under the actual Cigna and Wildflower contracts.

And that takes us directly back to the transparency problem:

providers are not being shown the Cigna agreement.

There is an additional patient-authority question

There is another layer that deserves examination.

In the arrangements providers have described, the patient may never independently contact Wildflower at all.

The patient sees the independent lactation provider.

The independent provider performs and documents the care.

The provider's own office staff then enters the claim information into the Wildflower process.

If that is the workflow, an obvious question follows:

What patient authorization, assignment, or other legal mechanism gives Wildflower an independent right to treat the reimbursement generated by that encounter as payment for Wildflower's own clinical service?

The provider contract unquestionably gives Wildflower authority to act as a billing and collection agent.

That establishes an agency relationship between the provider and Wildflower for billing.

But an agency relationship is not the same thing as proving that Wildflower independently owns the underlying clinical receivable or may represent itself as the provider that furnished care.

The reimbursement arises from healthcare services performed by the independent provider.

If the patient has never separately contracted with Wildflower, assigned benefits to Wildflower, or even interacted with Wildflower, then the basis for any claim that Wildflower independently owns that reimbursement deserves a clear explanation.

If Wildflower's position is that another document supplies that authority, providers should be able to identify that document.

Was there a patient assignment?

Was there a patient financial agreement with Wildflower?

Was the independent provider's receivable assigned to Wildflower?

Does the Cigna agreement create a special network payment structure?

Does some other contract authorize Wildflower to bill as the clinical entity?

Those questions can have answers.

But the answer should not simply be:

“Trust us. It's in the Cigna agreement you aren't allowed to see.”

A biller submitting a claim does not become the clinician who saw the patient

Wildflower's provider contract expressly grants it billing and collection authority.

What we have not found in either the MSA or the Cigna SOW is language authorizing Wildflower to represent itself as the clinician or clinical entity that actually rendered an independent provider's service.

There is no provision saying:

The contractor assigns its clinical services to Wildflower.

There is no provision saying:

The contractor becomes part of a Wildflower medical group.

There is no provision saying:

Wildflower shall be identified as the rendering provider for care furnished by the contractor.

And there is no provision turning independently owned lactation practices into Wildflower practice locations.

In fact, the master contract says almost the opposite

The MSA expressly describes Wildflower as an independent contractor.

It says the agreement does not create a partnership, joint venture, association, or other relationship beyond that independent-contractor relationship.

It also says the provider is contracting with Wildflower to obtain management services.

The contract separately says each party remains responsible for the actions of its own personnel and the services those personnel perform.

That does not read like a traditional group-practice agreement.

It reads exactly like what the document calls it:

A management company contracting with an independent healthcare practice.

If another agreement changes that, providers should be allowed to see it

Perhaps Wildflower's separate agreement with Cigna contains provisions explaining precisely how Cigna wants claims submitted.

Perhaps it establishes a unique network-payment arrangement.

Perhaps it gives Wildflower rights that do not appear in the provider-facing MSA or SOW.

That is possible.

But if Wildflower relies on that agreement to justify how a provider's clinical services, NPI, claims, or payments are handled, refusing providers visibility into the relevant terms creates the exact accountability problem this article is about.

The provider is being asked to accept Wildflower's interpretation of an agreement the provider cannot independently inspect.

That should not be normal.

Providers also have very limited leverage once they sign — individually

If a provider disputes Wildflower's actions, this is not a traditional contract where the obvious next step is simply to file a lawsuit.

The Management Services Agreement contains a binding arbitration provision.

Disputes are submitted to binding arbitration under the Commercial Rules of the American Arbitration Association.

The arbitration costs are divided equally between the parties, and the prevailing party may recover reasonable attorneys' fees and costs.

There is also a material-breach process.

And either party can terminate without cause.

But termination generally requires 90 days' written notice.

For one small lactation practice standing alone, that creates a very uneven practical relationship.

But individually is the important word.

Providers have more power than they sometimes realize

This industry has spent years treating payer and vendor contracting as something that happens to providers.

A contract appears.

Providers assume they have no choice.

The rules change.

Providers adapt.

The payment changes.

Providers absorb it.

That does not have to be the dynamic.

A provider network only functions if actual providers agree to participate.

Wildflower cannot provide nationwide lactation services to Cigna members through a network of independent clinicians without independent clinicians willing to remain in that network.

That gives providers leverage — especially when they communicate with one another, compare contracts, ask the same questions, and demand the same transparency.

This does not require anyone to tell another provider whether to sign or terminate a contract.

Each independent practice has to make that decision for itself.

But providers absolutely can insist on information before making that decision.

They can band together around transparency.

They can ask the same questions.

They can insist that vague references to confidential payer agreements are not enough.

They can collectively demand:

Show us the Provider Manual before we sign.

Explain how future changes become binding.

Show us the contractual authority for the claim structure.

Tell us which requirements actually originate with Cigna.

If you say Cigna requires something, provide the language supporting that claim.

Explain exactly how billing, rendering, pay-to, and service-facility information is being transmitted.

Transparency becomes much harder to avoid when providers stop asking those questions one at a time.

The timing of this new agreement deserves attention too

The timing of the new SOW is difficult to ignore.

Providers and advocates have been raising increasingly direct questions about Wildflower's reimbursement, billing structure, transparency, Cigna contracting relationship, and the authority underlying its claims practices.

Now, during that period of increased scrutiny, Wildflower has produced a replacement SOW that increases certain reimbursement rates and adds new language expressly binding providers to a Provider Manual and future Wildflower-issued policies.

We cannot prove from timing alone that provider pressure caused these changes.

But the timing is certainly notable.

And it demonstrates something providers should not overlook:

these arrangements are not fixed in stone.

Rates can change.

Contract terms can change.

Policies can change.

Businesses respond when enough pressure is applied to a problem.

That is exactly why providers should reject the idea that they have no power.

One provider asking for transparency can be dismissed.

A network of providers asking the same questions is much harder to ignore.

Wildflower is not synonymous with Cigna

Wildflower currently has a real relationship with Cigna.

That should not be confused with saying that Wildflower is Cigna.

It is not.

There are legitimate ways for qualifying healthcare providers and appropriately structured ancillary entities to pursue direct Cigna contracting outside of Wildflower.

That does not mean every standalone IBCLC in every state will qualify for a direct contract.

Provider type, licensure, entity structure, market, network need, and Cigna's contracting criteria all matter.

But providers should stop treating Wildflower as though it is automatically the only possible doorway to Cigna.

It is an intermediary with a payer relationship.

Those are not the same thing.

Cigna may still back Wildflower, but Wildflower still needs providers

Nothing about these concerns means Cigna has ended its relationship with Wildflower.

Cigna may continue to support the arrangement.

But Wildflower cannot operate a national lactation network without actual lactation providers willing to participate.

That is where provider power exists.

A network is not a contract between corporations.

A network is the clinicians who actually agree to see the patients.

If enough independent practices determine that the lack of transparency, contract structure, billing model, reimbursement, or unilateral policy authority is unacceptable, that affects Wildflower's ability to maintain the provider access the arrangement depends on.

Providers do not have to accept a contract simply because a large company presents it.

They can ask questions.

They can compare contracts.

They can choose other legitimate contracting pathways where available.

They can decline terms they do not accept.

And they can communicate with one another instead of negotiating in isolation.

Before signing this agreement, ask questions

Every provider considering this new SOW should be asking Wildflower, in writing:

Please provide the current Provider Manual that I am being asked to acknowledge receiving.

What notice will providers receive before the Manual is changed?

Do future Manual changes require my affirmative acceptance? If not, why not?

Which requirements originate with Cigna and which originate with Wildflower?

If Wildflower states that Cigna requires a particular billing or operational rule, will Wildflower provide the applicable contract language supporting that statement?

What provision of my agreement authorizes Wildflower to identify itself as the rendering provider, if Wildflower is doing so on claims for services I actually performed?

Am I considered part of a Wildflower group practice for claims purposes? If so, where does my contract establish that relationship?

If not, how are the billing and rendering NPIs being submitted to Cigna?

What entity is identified in each applicable billing-provider, rendering-provider, pay-to, and service-facility field?

What document gives Wildflower ownership of the reimbursement generated by my clinical service rather than merely authorizing Wildflower to collect that reimbursement on my behalf?

What patient authorization or assignment supports Wildflower's role when the patient never independently engaged Wildflower?

Those are basic questions about a provider's own services.

They should have straightforward answers.

A few more dollars per visit should not distract providers from what they are signing

Wildflower increased its in-person reimbursement.

Providers can decide for themselves whether the new rates are financially acceptable.

But $182 or $193 instead of $175 does not resolve the larger issues.

The 2026 agreement now expressly requires providers to comply with a Wildflower Provider Manual that Wildflower can change after signature.

Wildflower continues to invoke an underlying Cigna Provider Network Agreement that independent contractors cannot independently review.

The contract appoints Wildflower as a billing and collection agent for healthcare services performed by the contractor, but the agreements reviewed do not expressly establish Wildflower as the rendering clinician, convert independent practices into a Wildflower group practice, or expressly assign the contractor's clinical receivables to Wildflower.

And if providers disagree with Wildflower's interpretation of any of this, the agreement channels disputes into binding arbitration while allowing termination with 90 days' notice.

The timing of this replacement agreement — following increased provider scrutiny and pressure over Wildflower's reimbursement and business practices — is also worth paying attention to.

We cannot say the pressure caused the changes.

But providers should absolutely recognize what the changes themselves demonstrate:

providers have power when they use it.

Wildflower may have Cigna's backing.

It still needs providers willing to participate.

Providers are not required to negotiate alone.

They are not required to accept unexplained rules.

They are not required to stop asking questions because a company says an answer exists in a contract they are not allowed to see.

Providers can compare information.

They can demand transparency together.

They can explore legitimate direct contracting alternatives.

And they can decide whether the terms being offered are acceptable.

Before signing away more control, ask to see the rules.

Ask where the authority comes from.

Ask who owns the claim.

Ask who is being represented as having provided the care.

And when someone says:

“Cigna requires it,”

providers should be entitled to respond:

Show us where.